@FierceMedDev: Europe tables vote on tougher device regs. More | Follow @FierceMedDev
@MarkHFierce: We want your FMD Fierce 15 nominations. Send them in! More | Follow @MarkHFierce
@DamianFierce: Theragenics has signed a deal to get its brachytherapy products on the market in the EU. Story | Follow @DamianFierce
@MichaelGFierce: ICYMI: Avanir drops $110M on novel inhaled-delivery migraine device. Article | Follow @MichaelGFierce
> The FDA and the American Academy of Ophthalmology will sponsor a workshop on Oct. 11 designed to find ways to bring optical medical devices to market more quickly. Item
> Baxter ($BAX) reportedly is offering a number of concessions to the European Commission to ease antitrust concerns over its planned $4 billion merger with the Swedish dialysis company Gambro. Item
> CorMedix won a CE mark for its Neutrolin catheter lock, designed to cut the risk of bloodstream infections. More
> Seeking Alpha wrote a bullish piece on Nanosphere ($NSPH), a maker of molecular diagnostics that rely on gold nanoparticles. Item
> Makers of dialysis machines could see a 9.4% cut in Medicare payments--fallout from federal deficit-cutting efforts. Story
Biotech News
@FierceBiotech: SEC hunting down traders who made a quick killing on Onyx shares. Report | Follow @FierceBiotech
@JohnCFierce: Orexo stakes out $500M market for new opioid-addiction drug. More | Follow @JohnCFierce
@RyanMFierce: Xoma staffers form biotech startup to advance blood pressure med. News | Follow @RyanMFierce
@EmilyMFierce: In case you missed it over the holiday... Scientists create first regulatory map of tuberculosis. Report | Follow @EmilyMFierce
> Scientists score stem-cell victory with lab-grown liver tissue. Story
> Sarepta readies $125M raise to back muscular dystrophy drug work. Item
> Belgian biotech Cardio3 completes modest IPO. More
Pharma News
@FiercePharma: FDA to update generic labeling rules. Article | Follow @FiercePharma
@CarlyHFierce: ICYMI: Glass particles trigger another Fresenius Kabi recall. Story | Follow @CarlyHFierce
> Novartis' Lucentis gets its fourth approval in EU. News
> Orexo gets FDA approval for opioid addiction-fighting Zubsolv. Story
> Fresenius gets warning letter for India plant. More
Vaccines News
> Reliance on NIH threatens HIV vaccine funding. Story
> Polio discovery prompts Israeli vaccination push. More
> Merck KGaA: Lung cancer vaccine not dead. Article
> Study: Use of 2D barcodes could save healthcare $300M. News
> Novartis and Sanofi nab DoD vaccine contracts. Item